As a person ages, bone density can naturally decrease. Osteopenia is characterized by extremely low bone density, regardless of age. Read the full article about osteopenia vs. osteoporosis here: http://www.medicalnewstoday.com/articles/318321.php.
Washington, DC (June 13, 2017) – The National Osteoporosis Foundation (NOF), today issued the following statement in response to the Senate HELP hearing “The Cost of Prescription Drugs: How the Drug Delivery System Affects What Patients Pay” “During today’s hearing, several Senators raised the idea of allowing for the government to set prices in the… Read more »
To reduce the risk of hip and vertebral fractures in women with osteoporosis, physicians should treat them with the bisphosphonates risedronate, alendronate, or zoledronic acid, or alternatively with the biologic agent denosumab. This strong recommendation appears in revised guidelines from the American College of Physicians (ACP) for the prevention of fractures in men and women… Read more »
The National Osteoporosis Foundation frequently publishes position statements for the benefit of educating healthcare professionals and the general public on a particular issue and/or concern related to preventing osteoporosis and/or promoting strong bones throughout the lifespan. This manuscript represents the official methods and processes adopted by the NOF Board of Trustees for the purpose developing… Read more »
On July 14, 2016, the Centers for Medicare and Medicaid Services (CMS) published the proposed rule for the Hospital Outpatient Prospective Payment System (HOPPS) for 2017. CMS has proposed to cut the reimbursement rate for Axial DXA, CPT 77080 in the hospital setting from the current national average of $100.69 to $63.33. This reimbursement cut will… Read more »
The National Osteoporosis Foundation frequently publishes position statements for the benefit of educating healthcare professionals and the general public on a particular issue and/or concern related to preventing osteoporosis and/or promoting strong bones throughout the lifespan. As part of NOF’s Methods and Processes for Developing Position Statements, we welcome public input and comments to the… Read more »
Millions of Americans are missing out on a chance to avoid debilitating fractures from weakened bones, researchers say, because they are terrified of exceedingly rare side effects from drugs that can help them. Last month, the American Society for Bone and Mineral Research, the National Osteoporosis Foundation and the National Bone Health Alliance put out… Read more »
One our Corporate Advisory Roundtable members, Juvent, announced very positive results from the St. Jude Children’s Hospital Clinical Trial. An 11% increase in bone density was seen in childhood cancer survivors through their product, Juvent® Dynamic Motion Therapy Platform. The study was published in the Journal of the American Medical Association (JAMA) Oncology. To learn more,… Read more »
NOF is pleased to share interviews recorded by the Medicare Nation podcast, media partner for NOF’s annual conference, the Interdisciplinary Symposium on Osteoporosis, held May 12-15, 2016 in Miami, FL. Medicare Nation is a weekly podcast dedicated to bringing listeners everything they need to know about Medicare but are afraid to ask. They feature interviews… Read more »
The Nation’s leading scientific and medical bone health experts call for action on the dangers of not treating osteoporosis more aggressively. They are urging healthcare professionals to increase diagnosis and patients to be aware of this risk. Read statements released by leading organizations in the field in this PRNewswire article.